Af Advisors, Inc. Abb Vie Inc. Transaction History

Af Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $189,915 - $241,444	1,380 New	1,380 $211,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $195,330 - $242,350	-1,480 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $158,996 - $201,176	1,480 New	1,480 $200,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $191,520 - $217,404	-1,800 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $189,378 - $210,978	1,800 New	1,800 $203,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Af Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Af Advisors, Inc. with notifications on news.